Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

gastrointestinal · Mechanism Report

Does the ATG16L1 T300A genotype impair intestinal autophagy and promote dysbiosis and barrier dysfunction?

The ATG16L1 rs2241880 (T300A) variant disrupts epithelial autophagy, impairing bacterial clearance and contributing to persistent dysbiosis and reduced intestinal barrier integrity.

SupportedJune 19, 202617 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

The ATG16L1 rs2241880 (T300A) risk genotype can impair intestinal epithelial autophagy and bacterial handling, increasing susceptibility to persistent dysbiosis and barrier dysfunction.

laying out figure…
All 8 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The T300A substitution increases caspase-mediated cleavage of ATG16L1, causing loss of autophagy function in intestinal epithelial and Paneth cells. This defect reduces xenophagy and antimicrobial secretion, allowing shifts in the microbiota and promoting increased epithelial permeability and inflammatory signaling that compromise barrier function.

Verified conclusion

The ATG16L1 rs2241880 (T300A) polymorphism is a well-characterized genetic variant that significantly impacts the integrity of the intestinal environment by disrupting the autophagy pathway.

Mechanistic basis of autophagy impairment

The T300A variant involves a threonine-to-alanine substitution at position 300 of the ATG16L1 protein. This change creates a specific cleavage site for caspase-3 and caspase-7, enzymes involved in programmed cell death and inflammatory signaling.

  • Protein Instability: Under conditions of cellular stress or exposure to cytokines like TNF-α, the T300A variant undergoes accelerated proteolysis. This leads to a depletion of the full-length ATG16L1 protein required for autophagosome formation.
  • Paneth Cell Dysfunction: This defect is particularly critical in Paneth cells—specialized epithelial cells in the small intestine. The T300A genotype is associated with "hypomorphic" Paneth cells that exhibit disorganized granules and impaired secretion of antimicrobial peptides (e.g., α-defensins), which are essential for controlling the gut microbiota.

Bacterial handling and dysbiosis

The impairment of selective autophagy, or xenophagy, directly affects how the intestinal lining manages microbes.

  • Defective Xenophagy: Research in knock-in models and primary human cells shows that the T300A variant reduces the efficiency of trapping and degrading intracellular pathogens, such as Salmonella.
  • Persistent Dysbiosis: The combination of reduced antimicrobial secretion and failed bacterial clearance allows for shifts in the microbial community. Studies in Crohn’s disease cohorts indicate that this genotype promotes a pro-inflammatory bacterial profile and persistent dysbiosis.

Barrier dysfunction and clinical implications

The failure of these protective mechanisms leads to measurable declines in intestinal barrier function.

  • Increased Permeability: Deficient ATG16L1 activity results in heightened intestinal permeability and increased apoptosis (cell death) of the protective crypt cells.
  • Inflammatory Signaling: The inability to clear bacteria triggers chronic inflammatory responses, characterized by elevated levels of TNF-α and IFN-γ, which further degrade tight junction integrity.

Bottom line

The ATG16L1 T300A risk genotype increases susceptibility to caspase-mediated protein cleavage, which impairs epithelial autophagy. This defect compromises bacterial handling and Paneth cell function, leading to persistent dysbiosis and a weakened intestinal barrier.

References

  1. A Crohn’s disease variant in Atg16l1 enhances its degradation by caspase 3 — nature.com ↗
  2. Cell biology: Stressful genetics in Crohn's disease — pmc.ncbi.nlm.nih.gov ↗
  3. Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense — pmc.ncbi.nlm.nih.gov ↗
  4. Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense — pnas.org ↗
  5. Integrative analysis of Paneth cell proteomic data from intestinal organoids reveals functional processes affected in Crohn’s disease due to autophagy impairment — biorxiv.org ↗
  6. Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection. — pmc.ncbi.nlm.nih.gov ↗
  7. The Crohn’s disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response — elifesciences.org ↗
  8. Impact of T300A Variant of ATG16L1 on Antibacterial Response, Risk of Culture Positive Infections, and Clinical Course of Crohn's Disease — pmc.ncbi.nlm.nih.gov ↗
  9. Understanding Crohn's disease through genetics — tandfonline.com ↗
  10. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? — pmc.ncbi.nlm.nih.gov ↗
  11. ATG16L1 deficiency exacerbates acute small intestinal epithelial damage. — academic.oup.com ↗
  12. ATG16L1: A multifunctional susceptibility factor in Crohn disease — pmc.ncbi.nlm.nih.gov ↗
  13. Understanding Crohn's disease through genetics — pmc.ncbi.nlm.nih.gov ↗
  14. The Atg16l1 gene: characterization of wild type, knock-in, and knock-out phenotypes in rats — pmc.ncbi.nlm.nih.gov ↗
  15. Paneth cells as a site of origin for intestinal inflammation — nature.com ↗
  16. The roles and functions of Paneth cells in Crohn’s disease: A critical review — onlinelibrary.wiley.com ↗
  17. OP0205 Gut Dysbiosis in Patients with HLA-B27+ Ankylosing Spondylitis is Associated with Ileitis, Down-Regulation of Tight Junction Proteins, Increased Serum Levels of LPS and Monocytes Anergy — linkinghub.elsevier.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Unsupported12 sourcesCan reflux reaching the larynx and pharynx irritate upper-airway mucosa and relate to chronic rhinosinusitis?→Plausible11 sourcesDoes BabA-positive Helicobacter pylori bind gastric epithelial Lewis b antigens and promote inflammation?→